Page 2 - Pascal Deschatelets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Receives $76 67 Consensus Price Target from Analysts

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Receives $76 67 Consensus Price Target from Analysts
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw bairdCedric francoisPascal deschateletsInstitutional investors weigh in on apellis pharmaceuticalsNews ratings for apellis pharmaceuticals dailyApellis pharmaceuticalsAnalyst recommendations for apellis pharmaceuticalsFirst horizon advisors incApellis pharmaceuticals price performanceApellis pharmaceuticals company profileInsider transactions at apellis pharmaceuticalsSecurities exchange commissionApellis pharmaceuticals incNeedham companyFinancial wealth managment

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) to Post Q2 2024 Earnings of ($0 42) Per Share, Wedbush Forecasts

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) to Post Q2 2024 Earnings of ($0 42) Per Share, Wedbush Forecasts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Pascal deschateletsTimothy eugene sullivanSecurities exchange commissionInstitutional trading of apellis pharmaceuticalsApellis pharmaceuticals stock downCovestor ltdNews ratings for apellis pharmaceuticals dailyChina universal asset management coApellis pharmaceuticalsFinancial wealth managmentFirst horizon advisors incApellis pharmaceuticals incFree reportApellis pharmaceuticalGet free reportPharmaceuticals stock down

Apellis Pharmaceuticals (NASDAQ:APLS) Announces Quarterly Earnings Results, Meets Estimates

Apellis Pharmaceuticals (NASDAQ:APLS) Announces Quarterly Earnings Results, Meets Estimates
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Adamj townsendRaymond jamesPascal deschateletsApellis pharmaceuticals trading downSecurities exchange commissionApellis pharmaceuticalsApellis pharmaceuticals incNews ratings for apellis pharmaceuticals dailyJefferies financial groupEarnings history for apellis pharmaceuticalsGet free reportPharmaceuticals trading downExchange commissionApellis pharmaceuticals daily

Apellis Pharmaceuticals (NASDAQ:APLS) Issues Quarterly Earnings Results

Apellis Pharmaceuticals (NASDAQ:APLS) Issues Quarterly Earnings Results
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Adamj townsendPascal deschateletsApellis pharmaceuticals incApellis pharmaceuticalsJefferies financial groupNews ratings for apellis pharmaceuticals dailySecurities exchange commissionJpmorgan chase coApellis pharmaceuticals stock downEarnings history for apellis pharmaceuticalsNeedham companyGet free reportPharmaceuticals stock downExchange commissionFinancial groupApellis pharmaceuticals daily

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap Down to $48 81

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap Down to $48 81
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United kingdomPascal deschateletsRaymond jamesAdamj townsendZurcher kantonalbank zurich cantonalbankApellis pharmaceuticals stock performanceFirst horizon advisors incCambridge trust coCommonwealth equity servicesNews ratings for apellis pharmaceuticals dailyInstitutional investors weigh in on apellis pharmaceuticalsSecurities exchange commissionJpmorgan chase coApellis pharmaceuticalsApellis pharmaceuticals incYork mellon corp